Sign in
4

Changes in Ownership

Evommune, Inc. Filed Acc 0002092017-26-000007

Chief Scientific Officer sold 1,488 shares at $22.50 ($33,480)

  • Chief Scientific Officer acquired 1,488 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Patel Jeegar Pravinkumar Chief Scientific Officer 2026-06-22 Option exercise 10b5-1 +1,488 $3.84 $5,714 47,891 D
Patel Jeegar Pravinkumar Chief Scientific Officer 2026-06-22 Sale 10b5-1 −1,488 $22.50 $33,480 46,403 D
Derivatives
Patel Jeegar Pravinkumar Chief Scientific Officer 2026-06-22 Option exercise · Employee Stock Option (Right to Buy) 10b5-1 −1,488 27,842 D
Open-market sales · 1,488 sh · avg $22.50 · $33,480
Loading xslF345X06/primarydocument.xml…